Cargando…

Comparison of Residual Pulmonary Abnormalities 3 Months After Discharge in Patients Who Recovered From COVID-19 of Different Severity

Background and Objectives: To investigate whether coronavirus disease 2019 (COVID-19) survivors who had different disease severities have different levels of pulmonary sequelae at 3 months post-discharge. Methods: COVID-19 patients discharged from four hospitals 3 months previously, recovered asympt...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Mei, Xu, Juanjuan, Liao, Tingting, Yin, Zhengrong, Yang, Fan, Wang, Kai, Wang, Zhen, Yang, Dan, Wang, Sufei, Peng, Yi, Peng, Shuyi, Wu, Feihong, Chen, Leqing, Jin, Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8270002/
https://www.ncbi.nlm.nih.gov/pubmed/34249973
http://dx.doi.org/10.3389/fmed.2021.682087
_version_ 1783720707766616064
author Zhou, Mei
Xu, Juanjuan
Liao, Tingting
Yin, Zhengrong
Yang, Fan
Wang, Kai
Wang, Zhen
Yang, Dan
Wang, Sufei
Peng, Yi
Peng, Shuyi
Wu, Feihong
Chen, Leqing
Jin, Yang
author_facet Zhou, Mei
Xu, Juanjuan
Liao, Tingting
Yin, Zhengrong
Yang, Fan
Wang, Kai
Wang, Zhen
Yang, Dan
Wang, Sufei
Peng, Yi
Peng, Shuyi
Wu, Feihong
Chen, Leqing
Jin, Yang
author_sort Zhou, Mei
collection PubMed
description Background and Objectives: To investigate whether coronavirus disease 2019 (COVID-19) survivors who had different disease severities have different levels of pulmonary sequelae at 3 months post-discharge. Methods: COVID-19 patients discharged from four hospitals 3 months previously, recovered asymptomatic patients from an isolation hotel, and uninfected healthy controls (HCs) from the community were prospectively recruited. Participants were recruited at Wuhan Union Hospital and underwent examinations, including quality-of-life evaluation (St. George Respiratory Questionnaire [SGRQ]), laboratory examination, chest computed tomography (CT) imaging, and pulmonary function tests. Results: A total of 216 participants were recruited, including 95 patients who had recovered from severe/critical COVID-19 (SPs), 51 who had recovered from mild/moderate disease (MPs), 28 who had recovered from asymptomatic disease (APs), and 42 HCs. In total, 154 out of 174 (88.5%) recovered COVID-19 patients tested positive for serum SARS-COV-2 IgG, but only 19 (10.9%) were still positive for IgM. The SGRQ scores were highest in the SPs, while APs had slightly higher SGRQ scores than those of HCs; 85.1% of SPs and 68.0% of MPs still had residual CT abnormalities, mainly ground-glass opacity (GGO) followed by strip-like fibrosis at 3 months after discharge, but the pneumonic lesions were largely absorbed in the recovered SPs or MPs relative to findings in the acute phase. Pulmonary function showed that the frequency of lung diffusion capacity for carbon monoxide abnormalities were comparable in SPs and MPs (47.1 vs. 41.7%), while abnormal total lung capacity (TLC) and residual volume (RV) were more frequent in SPs than in MPs (TLC, 18.8 vs. 8.3%; RV, 11.8 vs. 0%). Conclusions: Pulmonary abnormalities remained after recovery from COVID-19 and were more frequent and conspicuous in SPs at 3 months after discharge.
format Online
Article
Text
id pubmed-8270002
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-82700022021-07-10 Comparison of Residual Pulmonary Abnormalities 3 Months After Discharge in Patients Who Recovered From COVID-19 of Different Severity Zhou, Mei Xu, Juanjuan Liao, Tingting Yin, Zhengrong Yang, Fan Wang, Kai Wang, Zhen Yang, Dan Wang, Sufei Peng, Yi Peng, Shuyi Wu, Feihong Chen, Leqing Jin, Yang Front Med (Lausanne) Medicine Background and Objectives: To investigate whether coronavirus disease 2019 (COVID-19) survivors who had different disease severities have different levels of pulmonary sequelae at 3 months post-discharge. Methods: COVID-19 patients discharged from four hospitals 3 months previously, recovered asymptomatic patients from an isolation hotel, and uninfected healthy controls (HCs) from the community were prospectively recruited. Participants were recruited at Wuhan Union Hospital and underwent examinations, including quality-of-life evaluation (St. George Respiratory Questionnaire [SGRQ]), laboratory examination, chest computed tomography (CT) imaging, and pulmonary function tests. Results: A total of 216 participants were recruited, including 95 patients who had recovered from severe/critical COVID-19 (SPs), 51 who had recovered from mild/moderate disease (MPs), 28 who had recovered from asymptomatic disease (APs), and 42 HCs. In total, 154 out of 174 (88.5%) recovered COVID-19 patients tested positive for serum SARS-COV-2 IgG, but only 19 (10.9%) were still positive for IgM. The SGRQ scores were highest in the SPs, while APs had slightly higher SGRQ scores than those of HCs; 85.1% of SPs and 68.0% of MPs still had residual CT abnormalities, mainly ground-glass opacity (GGO) followed by strip-like fibrosis at 3 months after discharge, but the pneumonic lesions were largely absorbed in the recovered SPs or MPs relative to findings in the acute phase. Pulmonary function showed that the frequency of lung diffusion capacity for carbon monoxide abnormalities were comparable in SPs and MPs (47.1 vs. 41.7%), while abnormal total lung capacity (TLC) and residual volume (RV) were more frequent in SPs than in MPs (TLC, 18.8 vs. 8.3%; RV, 11.8 vs. 0%). Conclusions: Pulmonary abnormalities remained after recovery from COVID-19 and were more frequent and conspicuous in SPs at 3 months after discharge. Frontiers Media S.A. 2021-06-25 /pmc/articles/PMC8270002/ /pubmed/34249973 http://dx.doi.org/10.3389/fmed.2021.682087 Text en Copyright © 2021 Zhou, Xu, Liao, Yin, Yang, Wang, Wang, Yang, Wang, Peng, Peng, Wu, Chen and Jin. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Zhou, Mei
Xu, Juanjuan
Liao, Tingting
Yin, Zhengrong
Yang, Fan
Wang, Kai
Wang, Zhen
Yang, Dan
Wang, Sufei
Peng, Yi
Peng, Shuyi
Wu, Feihong
Chen, Leqing
Jin, Yang
Comparison of Residual Pulmonary Abnormalities 3 Months After Discharge in Patients Who Recovered From COVID-19 of Different Severity
title Comparison of Residual Pulmonary Abnormalities 3 Months After Discharge in Patients Who Recovered From COVID-19 of Different Severity
title_full Comparison of Residual Pulmonary Abnormalities 3 Months After Discharge in Patients Who Recovered From COVID-19 of Different Severity
title_fullStr Comparison of Residual Pulmonary Abnormalities 3 Months After Discharge in Patients Who Recovered From COVID-19 of Different Severity
title_full_unstemmed Comparison of Residual Pulmonary Abnormalities 3 Months After Discharge in Patients Who Recovered From COVID-19 of Different Severity
title_short Comparison of Residual Pulmonary Abnormalities 3 Months After Discharge in Patients Who Recovered From COVID-19 of Different Severity
title_sort comparison of residual pulmonary abnormalities 3 months after discharge in patients who recovered from covid-19 of different severity
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8270002/
https://www.ncbi.nlm.nih.gov/pubmed/34249973
http://dx.doi.org/10.3389/fmed.2021.682087
work_keys_str_mv AT zhoumei comparisonofresidualpulmonaryabnormalities3monthsafterdischargeinpatientswhorecoveredfromcovid19ofdifferentseverity
AT xujuanjuan comparisonofresidualpulmonaryabnormalities3monthsafterdischargeinpatientswhorecoveredfromcovid19ofdifferentseverity
AT liaotingting comparisonofresidualpulmonaryabnormalities3monthsafterdischargeinpatientswhorecoveredfromcovid19ofdifferentseverity
AT yinzhengrong comparisonofresidualpulmonaryabnormalities3monthsafterdischargeinpatientswhorecoveredfromcovid19ofdifferentseverity
AT yangfan comparisonofresidualpulmonaryabnormalities3monthsafterdischargeinpatientswhorecoveredfromcovid19ofdifferentseverity
AT wangkai comparisonofresidualpulmonaryabnormalities3monthsafterdischargeinpatientswhorecoveredfromcovid19ofdifferentseverity
AT wangzhen comparisonofresidualpulmonaryabnormalities3monthsafterdischargeinpatientswhorecoveredfromcovid19ofdifferentseverity
AT yangdan comparisonofresidualpulmonaryabnormalities3monthsafterdischargeinpatientswhorecoveredfromcovid19ofdifferentseverity
AT wangsufei comparisonofresidualpulmonaryabnormalities3monthsafterdischargeinpatientswhorecoveredfromcovid19ofdifferentseverity
AT pengyi comparisonofresidualpulmonaryabnormalities3monthsafterdischargeinpatientswhorecoveredfromcovid19ofdifferentseverity
AT pengshuyi comparisonofresidualpulmonaryabnormalities3monthsafterdischargeinpatientswhorecoveredfromcovid19ofdifferentseverity
AT wufeihong comparisonofresidualpulmonaryabnormalities3monthsafterdischargeinpatientswhorecoveredfromcovid19ofdifferentseverity
AT chenleqing comparisonofresidualpulmonaryabnormalities3monthsafterdischargeinpatientswhorecoveredfromcovid19ofdifferentseverity
AT jinyang comparisonofresidualpulmonaryabnormalities3monthsafterdischargeinpatientswhorecoveredfromcovid19ofdifferentseverity